Regeneron/Sanofi to cut price of heart drug in Express Scripts deal
(Reuters) - Regeneron Pharmaceuticals and Sanofi will cut the net price of their expensive cholesterol drug for Express Scripts customers in exchange for greater patient access, with some savings to be shared with consumers, the companies said on Tuesday.
from Reuters: Health News https://reut.rs/2rcTeL7
http://bit.ly/2zwRqiM